Skip Navigation


Carcinogenesis Advance Access originally published online on August 11, 2007
Carcinogenesis 2007 28(12):2476-2483; doi:10.1093/carcin/bgm186
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/12/2476    most recent
bgm186v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shao, J.
Right arrow Articles by Sheng, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shao, J.
Right arrow Articles by Sheng, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin

Jinyi Shao, M.Kay Washington1, Romil Saxena2 and Hongmiao Sheng*

Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
1 Department of Pathology, Vanderbilt University, Nashville, TN 37232, USA
2 Department of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA

* To whom correspondence should be addressed. Tel: +317-274-2630; Fax: +317-274-7334;Email: hsheng{at}iupui.edu

The persistent activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway is oncogenic and involved in colorectal neoplasia. Mutations of both regulatory subunit and catalytic subunit of PI3K have been demonstrated in colon cancers. In the present study, we show that heterozygous disruption of the phosphatase and tensin homolog (PTEN) tumor suppressor gene promoted tumor progression in APCmin/+ mice. Number and size of intestinal tumors were significantly increased in mice bearing both adenomatous polyposis coli (APC) and PTEN mutations. While APCmin/+PTEN+/+ mice developed adenomas, invasive carcinomas developed in APCmin/+PTEN+/– mice. Large tumors often resulted in intestinal intussusception and early death of APCmin/+PTEN+/– mice. Targeted array revealed that osteopontin (OPN) was the leading gene whose expression was strongly induced by deficiency of PTEN. In colon cancer cells, gain-of-function mutation of PI3K robustly increased levels of OPN and treatment with OPN reduced growth factor deprivation-induced programmed cell death. Moreover, OPN expression was strongly increased in Ras-induced transformation of intestinal epithelial cells in a PI3K-dependent manner. Inhibition of OPN expression by specific small interfering RNA reduced uncontrolled growth and invasiveness of Ras-transformed intestinal epithelial cells. Thus, our results suggest that the PI3K pathway promotes the transformation of intestinal adenoma to adenocarcinoma. OPN, a downstream effector of PI3K, protects transformed intestinal epithelial cells from programmed cell death and stimulates their anchorage-independent growth.

Abbreviations: ELISA, enzyme-linked immunosorbent assay; IPTG, isopropyl-1-thio-β-D-galactopyranoside; mRNA, messenger RNA; OPN, osteopontin; RT–PCR, reverse transcription–polymerase chain reaction; siRNA, small interfering RNA

Received April 5, 2007; revised August 3, 2007; accepted August 5, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
M.-J. Langlois, S. A. B. Roy, B. A. Auclair, C. Jones, F. Boudreau, J. C. Carrier, N. Rivard, and N. Perreault
Epithelial phosphatase and tensin homolog regulates intestinal architecture and secretory cell commitment and acts as a modifier gene in neoplasia
FASEB J, June 1, 2009; 23(6): 1835 - 1844.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. H. El Touny and P. P. Banerjee
Identification of a Biphasic Role for Genistein in the Regulation of Prostate Cancer Growth and Metastasis
Cancer Res., April 15, 2009; 69(8): 3695 - 3703.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.